Sialylation modulates basophil responsiveness to galectin-3–dependent activation
Journal of Leukocyte Biology · 03.07.2026 · 118 (7)
DOI: 10.1093/jleuko/qiag087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 26.06.2026. Verfasst von Laurent Ehrlich und 5 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins Asthma and Allergy Center, Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University, 5501 Hopkins …. Hauptthemen laut MEDLINE: Basophils, Galectin 3. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, NIH HHS.
Abstract (Originalsprache)
Basophils secrete histamine and IL-4/13 when cocultured with human lung adenocarcinoma cells (A549 cells). Previous studies have revealed that this interaction is dependent on galectin-3 expression on the surface of A549 cells (EC-Gal-3), IgE present on the surface of IL-3 primed basophils, and direct physical interaction between the two cell types, indicating a cognate interaction between IgE and Gal-3. Reciprocal secretion of protumorigenic cytokines (IL-6/VEGF-A) from A549 cells also results. Here, we further define the biological parameters required for this mode of activation. EC-Gal-3 stimulus has ∼20-fold less IgE crosslinking capacity compared with standard anti-IgE. The capacity of IgE-bearing basophils to elicit an EC-Gal-3–mediated response correlates with their responsiveness to standard anti-IgE stimulation, which is known to vary widely among individuals. However, unlike standard anti-IgE stimulation, basophil releasability in response to EC-Gal-3 is influenced by glycosylation patterns on surface-bound IgE. Specifically, bulk sialylation on IgE molecules suppress cellular releasability. Whole-cell basophil sialylation also suppresses EC-Gal-3 mediated activation. Gal-3 is an endogenous lectin with multivalent binding capacity and is implicated in a range of diseases involving immune modulation, organ fibrosis, and tumor metastasis. These results can help identify specific physiological and pathophysiological conditions by which IgE:Gal-3 interactions drive disease processes including wound healing, cancer, and fibrosis, including that which occurs in asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Johns Hopkins Asthma and Allergy Center, Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, United States.
- Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown, MA 02129,…
ORCID-Profile: Laurent Ehrlich, John T Schroeder
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- National Institutes of Health
Zitieren
APA
Ehrlich, L., MacGlashan, D. W., Anthony, R., Conroy, M., Bieneman, A. P., & Schroeder, J. T. (2026). Sialylation modulates basophil responsiveness to galectin-3–dependent activation. Journal of Leukocyte Biology, 118(7). https://doi.org/10.1093/jleuko/qiag087
Vancouver
Ehrlich L, MacGlashan DW, Anthony R, Conroy M, Bieneman AP, Schroeder JT. Sialylation modulates basophil responsiveness to galectin-3–dependent activation. Journal of Leukocyte Biology. 2026;118(7). doi:10.1093/jleuko/qiag087
BibTeX
@article{Ehrlich2026,
author = {Ehrlich, Laurent and MacGlashan, Donald W and Anthony, Robert and Conroy, Michelle and Bieneman, Anja P and Schroeder, John T},
title = {Sialylation modulates basophil responsiveness to galectin-3–dependent activation},
journal = {Journal of Leukocyte Biology},
year = {2026},
volume = {118},
number = {7},
doi = {10.1093/jleuko/qiag087}
}
EUVIMED